国内外川崎病临床诊断研究进展
Progress in Clinical Diagnosis of International Kawasaki Disease
DOI: 10.12677/ACM.2019.97131, PDF,   
作者: 吕菊红, 马红茹：陕西省宝鸡市中心医院儿科，陕西 宝鸡；邓 峰：陕西省宝鸡市疾病预防控制中心，陕西 宝鸡
关键词: 川崎病；临床诊断；国际；Kawasaki Disease； Clinical Diagnosis； International
摘要: 川崎病是一种主要发生于5岁及以下儿童的系统性血管炎，已成为发达国家后天性儿童心脏病的主要原因。自全球首个川崎病研究报道至今，已过去了半个世纪，有关川崎病的临床诊断研究各国研究进展不一。我国川崎病发病率总体呈逐年上升趋势，提高川崎病临床诊断水平显得十分重要。本文对国内外川崎病临床诊断标准进行综述，旨在为提高我国川崎病临床诊断水平提供参考。
Abstract: Kawasaki disease is a systemic vasculitic disease mainly occurring in children aged 5 years and younger. It has become a major cause of heart disease in acquired children in developed countries. Since the world’s first Kawasaki disease research report, it has been half a century since the re-search on clinical diagnosis of Kawasaki disease has been different. The incidence of Kawasaki disease in China is generally increasing year by year, and it is very important to improve the clinical diagnosis level of Kawasaki disease. This article reviews the clinical diagnostic criteria of Kawasaki disease at home and abroad, and aims to provide a reference for improving the clinical diagnosis of Kawasaki disease in China.
文章引用：吕菊红, 马红茹, 邓峰. 国内外川崎病临床诊断研究进展[J]. 临床医学进展, 2019, 9(7): 852-859. https://doi.org/10.12677/ACM.2019.97131

参考文献

[1] Kawasaki, T. (2006) Kawasaki Disease. Proceedings of the Japan Academy. Series B, Physical and Biological Sciences, 82, 59-71. [Google Scholar] [CrossRef] [PubMed]
[2] Weiss, P.F. (2012) Pediatric Vasculitis. Pediatric Clinics of North America, 59, 407-423. [Google Scholar] [CrossRef] [PubMed]
[3] McCrindle, B.W., Rowley, A.H., Newburger, J.W., et al. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Profes-sionals from the American Heart Association. Circulation, 135, 927-999. [Google Scholar] [CrossRef] 
[4] 梁翊常, 王乃坤, 柴晓敏. 我国川崎病概况[J]. 中国实用儿科杂志, 1995, 5(10): 302-303.
[5] 杜忠东, 陈笑征. 川崎病流行病学研究进展[J]. 中国实用儿科杂志, 2017, 32(8): 565-569.
[6] 张新艳, 杨婷婷, 何婷, 等. 2012至2016年单中心川崎病流行病学及临床特征研究[J]. 中国循证儿科杂志, 2018, 13(6): 427-432.
[7] Hedrich, C., Schnabel, A. and Hospach, T. (2018) Kawasaki Disease. Frontiers in Pediatrics, 6, 198. [Google Scholar] [CrossRef] [PubMed]
[8] 阮瑜, 赵晓东. 川崎病诊断标准的变迁[J]. 儿科药学杂志, 2012, 18(1): 1-4.
[9] 余艳萍, 阿布来提•阿不都哈尔. 川崎病诊断与治疗新进展[J]. 中华临床医师杂志(电子版), 2016, 10(4): 566-570.
[10] Kawasaki, T. (1967) Acute Febrile Mucocutaneous Syndrome with Lymphoid Involvement with Specific Desquamation of the Fingers and Toes in Children. Arerugi, 16, 178-222.
[11] Kawasaki, T., Kosaki, F., Okawa, S., et al. (1974) A New Infantile Acute Febrile Mucocutaneous Lymph Node Syndrome (MLNS) Prevailing in Japan. Pediatrics, 54, 271-276.
[12] Burns, J.C., Wiggins, J.W., Toews, W.H., et al. (1986) Clinical Spectrum of Ka-wasaki Disease in Infants Younger than 6 Months of Age. The Journal of Pediatrics, 109, 759-763. [Google Scholar] [CrossRef] 
[13] Kim, D.S. (2006) Kawasaki Disease. Yonsei Medical Journal, 47, 759-772. [Google Scholar] [CrossRef] [PubMed]
[14] O’Loughlin, J.E. (1989) Management of Kawasaki Syndrome: A Consensus Statement Prepared by North American Participants of the Third International Kawasaki Disease Symposium, Tokyo, Japan, December, 1988. The Pediatric Infectious Disease Journal, 8, 663-667. [Google Scholar] [CrossRef] 
[15] Ayusawa, M., Sonobe, T., Uemura, S., et al. (2005) Revision of Diagnostic Guidelines for Kawasaki Disease (the 5th Revised Edition). Pediatrics International, 47, 232-234. [Google Scholar] [CrossRef] [PubMed]
[16] Newburger, J.W., Taubert, K.A., Shulman, S.T., et al. (2003) Summary and Abstracts of the Seventh International Kawasaki Disease Symposium: December 4-7, 2001, Hakone, Japan. Pediatric Research, 53, 153-157. [Google Scholar] [CrossRef] [PubMed]
[17] Burns, J.C., Kushner, H.I., Bastian, J.F., et al. (2000) Kawasaki Disease: A Brief History. Pediatrics, 106, 27. [Google Scholar] [CrossRef] [PubMed]
[18] Newburger, J.W., Takahashi, M., Gerber, M.A., et al. (2004) Diag-nosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals from the Committee on Rheumatic Fev, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation, 110, 2747-2771. [Google Scholar] [CrossRef] 
[19] Marchesi, A., Tarissi, I., Rigante, D., et al. (2018) Kawasaki Disease: Guidelines of the Italian Society of Pediatrics, Part I Definition, Epidemiology, Etiopathogenesis, Clinical Expression and Management of the Acute Phase. Italian Journal of Pediatrics, 44, 102. [Google Scholar] [CrossRef] [PubMed]
[20] Marchesi, A., Tarissi, I., Rigante, D., et al. (2018) Kawasaki Disease: Guidelines of Italian Society of Pediatrics, Part II Treatment of Resistant Forms and Cardiovascular Compli-cations, Follow-Up, Lifestyle and Prevention of Cardiovascular Risks. Italian Journal of Pediatrics, 44, 103. [Google Scholar] [CrossRef] [PubMed]
[21] Pilania, R.K., Bhattarai, D. and Singh, S. (2018) Controversies in Diagnosis and Management of Kawasaki Disease. World Journal of Clinical Pediatrics, 7, 27-35. [Google Scholar] [CrossRef] [PubMed]
[22] Moore, A., Harnden, A. and Mayon-White, R. (2014) Recognising Kawasaki Disease in UK Primary Care: A Descriptive Study Using the Clinical Practice Research Datalink. British Journal of General Practice, 64, e477-e483. [Google Scholar] [CrossRef] 
[23] Boudiaf, H. and Achir, M. (2016) The Clinical Profile of Kawasaki Disease in Algerian Children: A Single Institution Experience. Journal of Tropical Pediatrics, 62, 139-143. [Google Scholar] [CrossRef] [PubMed]
[24] Rowley, A.H. (2015) The Complexities of the Diagnosis and Man-agement of Kawasaki Disease. Infectious Disease Clinics of North America, 29, 525-537. [Google Scholar] [CrossRef] [PubMed]
[25] Seo, Y.-M., Kang, H.-M., Lee, S.-C., et al. (2018) Clinical Impli-cations in Laboratory Parameter Values in Acute Kawasaki Disease for Early Diagnosis and Proper Treatment. Korean Journal of Pediatrics, 61, 160-166. [Google Scholar] [CrossRef] [PubMed]
[26] 赵晓东, 杜忠东. 川崎病专题讨论会纪要[J]. 中华儿科杂志, 2007, 45(11): 826-830.
[27] 李雪琴, 吕菊红, 李文君. 血浆端脑利钠肽前体测定在不完全川崎病患儿早期诊断的临床意义[J]. 山西医科大学学报, 2014, 45(3): 227-229.
[28] 王祥, 陈智, 肖云彬, 等. 血Ｎ末端脑利钠肽原和降钙素原在川崎病诊断中的价值[J]. 中国中西医结合儿科学, 2017, 9(4): 301-303.
[29] 李雪琴, 吕菊红, 李文君. 血浆N末端B型利钠肽原与C反应蛋白在小儿川崎病中的变化及临床意义[J]. 中国临床研究, 2014, 27(5): 583-584.
[30] 张丽君. 血清淀粉样蛋白Ａ检测在儿童川崎病诊断中的价值[J]. 预防医学论坛, 2018, 24(5): 390-392.
[31] 陈灵红, 林红霞, 杨德华. 血清淀粉样蛋白A对川崎病诊断的临床应用价值[J]. 浙江中西医结合杂志, 2017, 27(9): 770-773.
[32] 邓永超, 唐喜春, 杨娟, 等. 平均血小板质量与降钙素原在儿童川崎病诊断中的应用价值[J]. 现代检验医学杂志, 2016, 31(5): 144-146.
[33] 郑瑞利, 何坤, 董湘玉. 川崎病易感基因的研究进展[J]. 中西医结合心血管病杂志, 2017, 5(33): 18-21.
[34] 吴镇宇, 姚丽萍. 与川崎病发病及冠状动脉损伤相关的易感基因[J]. 中外医疗, 2016, 35(16): 197-198.
[35] 蒋勇, 李敬风. FCGＲ2A基因rs1801274位点基因多态性与川崎病相关性研究的Meta分析[J]. 现代医学, 2017, 45(4): 465-471.

为你推荐